| Document |
Document Title |
|
WO/2020/181012A1 |
The present disclosure relates to optically transparent plant-derived products that are capable of dissolution in water.
|
|
WO/2020/179805A1 |
Provided is a method for producing a powder compact, which can improve hardness while suppressing a decrease in production efficiency of the powder compact. A powder compact 14 is compression-molded by compressing the powder supplied int...
|
|
WO/2020/177153A1 |
The present invention belongs to the technical field of medicine, and provides a pharmaceutical or health food composition of nicotinamide mononucleotide and mogroside. In addition, the present invention also provides a preparation metho...
|
|
WO/2020/175939A1 |
The present invention relates to novel Weissella hellenica WiKim0103, isolated from kimchi, and a composition comprising same, or uses of same. The present invention provides a method for preventing, alleviating, and treating inflammatio...
|
|
WO/2020/175274A1 |
Provided is a food/beverage product that contains dietary fiber, vitamins, and a source of calcium but ameliorates the off flavors that arise from said nutritional components. Also provided are an off-flavor masking agent for the food/be...
|
|
WO/2020/176758A1 |
Methods of production of edible filamentous fungal biomat formulations are provided as standalone protein sources and/or protein ingredients in foodstuffs as well as a one-time use or repeated use self-contained biomat reactor comprising...
|
|
WO/2020/176734A1 |
This specification relates to a method for reducing the amount of lactose in a milk-based substrate containing lactose, wherein said method comprises contacting said substrate with an enzyme having neutral lactase activity at a temperatu...
|
|
WO/2020/091179A9 |
The present invention provides a Lactobacillus plantarum A41 strain with accession number KCTC13686BP, and pharmaceutical and food compositions comprising, as an active ingredient, the strain or a culture thereof. The strain according to...
|
|
WO/2020/172217A1 |
A process cheese produced by a combination of an acid curd and a concentrated milk protein at specific ratios is disclosed. The process cheese is produced without an emulsifying salt. A method of producing the process cheese is disclosed...
|
|
WO/2020/170776A1 |
A method for producing a culture by culturing a lactic acid bacterium and/or a bacterium belonging to the genus Bifidobacterium in a milk peptide-containing medium to give the culture, characterized in that the culture temperature is low...
|
|
WO/2020/169438A1 |
The appliance (1) for the production of dairy products comprises a hollow body (2) and a closing cover (3) delimiting with the hollow body (2) a housing compartment (4), a containment tank (5) arranged with an axis extending vertically (...
|
|
WO/2020/170117A1 |
The present invention relates to a method for producing milk and/or a derivative thereof enriched with at least one lipid-lowering substance, preferably monacolin k, comprising the steps of: (a) administering to a dairy ruminant a ration...
|
|
WO/2020/171068A1 |
The purpose of the present invention is to provide: a milk protein-containing granular composition which exhibits favorable dispersion properties in a solvent such as water and suppresses changes in color over time; a method for producin...
|
|
WO/2020/170840A1 |
The present invention addresses the problem of providing a novel crystal of 2-O-α-D-glucosyl-L-ascorbic acid and a method for producing the crystal. The problem is solved by providing a crystal of the potassium salt of 2-O-α-D-glucosyl...
|
|
WO/2020/168439A1 |
The present invention provides a novel process for preparing fortified milk compositions from whole mammalian milk. The process of the present invention generally involves converting dried mammalian milk into a fats-enriched fraction, a ...
|
|
WO/2020/166527A1 |
[Problem] To provide: a food or beverage for babies and infants, which can improve the intestinal environment of a baby or an infant to enhance the immunity of the baby or the infant; and others. [Solution] A food or beverage for babies ...
|
|
WO/2020/168150A1 |
Formulation and dispenser systems create dairy based toppings for beverages. The dispensers include a container, valve, and an actuator for the valve. The formulations include a liquid product and a propellant. The liquid product include...
|
|
WO/2020/161286A1 |
The invention relates to a method for creating a cold mixed drink made of milk and an acidic component, comprising: A step of denaturing the milk. Here, prior to mixing with an acidic component, the milk is heated to a denaturing tempera...
|
|
WO/2020/130065A9 |
The present invention provides an infant formula liquid milk characterized in containing calcium hydroxide and having a pH of 6.9 to 7.3.
|
|
WO/2020/163381A1 |
This invention is directed to compositions and methods to detect and treat gastrointestinal diseases.
|
|
WO/2020/161113A1 |
The present invention concerns improving sleep in infants by administering nutrition that is at least partly fermented by lactic acid producing bacteria and comprises non-digestible oligosaccharides.
|
|
WO/2020/157209A1 |
A method for making a flavour modifying ingredient, the method comprising subjecting a dietary fibre to enzymatic hydrolysis and/or fermentation; flavour modifying ingredients obtainable by said method; flavour compositions and food prod...
|
|
WO/2020/159910A1 |
Systems and methods of making lactobionic acid are described. The systems include two-compartment cation bipolar electrodialysis assemblies having at least one cell that includes a cation ion-exchange membrane and a bipolar membrane. The...
|
|
WO/2020/152229A1 |
It is provided a yeast product for use as a prebiotic agent, and a composition comprising it. It is also provided the non-therapeutic use of a yeast product, and a composition comprising it, as a prebiotic agent. The yeast product, and t...
|
|
WO/2020/154565A1 |
This specification relates to preparing a purified human milk oligosaccharide (HMO) from an HMO solution by a process comprising nanofiltration, as well as processes for making foods, dietary supplements, medicines and infant formulas co...
|
|
WO/2020/148362A1 |
The present invention relates to uses of an enzyme having beta-galactosidase activity and being derived from Paenibacillus wynnii in the production of lactose-depleted or lactose-free dairy products and/or of galacto-oligosaccharide-enri...
|
|
WO/2020/135678A1 |
A device for use in making a yoghurt product, the device including: a base station having a reservoir associated therewith for holding a yoghurt product pre-mixture; a stirrer for stirring the yoghurt product pre-mixture; a heating devic...
|
|
WO/2020/138769A1 |
The present invention relates to an anti-helicobacter food composition which exhibits excellent ability to kill Helicobacter pyroli present in the gastrointestinal tract by using beta-caryophyllene, wherein the anti-helicobacter food com...
|
|
WO/2020/138026A1 |
The present invention addresses the problem of providing a novel heat stress alleviation agent that can be taken simply, safely, and easily, even by infants and the elderly, who are susceptible to heat stress such as heatstroke, that rap...
|
|
WO/2020/139086A1 |
The present invention relates to a liquid composition comprised of a micellar casein concentrate (MCC), more specifically a MCC that is of non-bovine origin. The present invention further relates to food products comprised of the liquid ...
|
|
WO/2020/126726A1 |
The present invention relates to nutritional compositions comprising 2'- Fucosyllactose (2'FL) for use in improving the gastrointestinal barrier. In particular, the present invention relates to improving gastrointestinal barrier in an in...
|
|
WO/2020/128063A1 |
A drinkable infant composition comprising two or more food allergens wherein one of said food allergens is milk protein.
|
|
WO/2020/127511A1 |
The disclosure relates generally to dairy compositions comprising lactose hydrolysis products such as preferably glucose and galactose optionally further in combination with unhydrolysed lactose, and glucosylated natural steviol glycosid...
|
|
WO/2020/126536A1 |
The invention relates to a nutritional composition for infants and young children comprising proteins, carbohydrates and lipids, wherein said proteins comprise ionic complexes of lactoferrin with acid milk proteins, said complexes having...
|
|
WO/2020/127144A1 |
The present invention relates to a method for obtaining a bacteriophage insensitive mutant (BIM) of a lactic acid bacterium parent strain suitable for food and feed fermentation. Further, the present invention relates to a method for the...
|
|
WO/2020/128084A1 |
A process for preparing a fermented dairy product matching with warm flavouring agents is disclosed. A dairy composition is first prepared by mixing an egg-and-milk powder with a dairy base. Thereafter, the dairy composition is homogeniz...
|
|
WO/2020/128082A1 |
A yoghurt which remains heat-stable at a cooking temperature of 120°C for a time of at least 5 minutes is disclosed. The yoghurt has a pH ranging from 4.0 to 5.5 and comprises Streptococcus thermophilus and Lactobacillus delbruekii subs...
|
|
WO/2020/131299A1 |
A dairy product comprising a sweetened dairy composition with a mass ratio of lactose to glucose equal to 1.0:2.7 to 2.6:1.5 and a mass ratio of lactose to galactose equal to 1.0:2.2 to 2.6:1.1. In a second aspect, a method comprises hyd...
|
|
WO/2020/126734A1 |
The present invention relates to nutritional compositions comprising 2'-Fucosyllactose (2'FL), Di-fucosyllactose (DiFL), Lacto-N-tetraose (LNT), Lacto-N-neotetraose (LNnT), 3'-Sialyllactose (3'SL) and 6'-Sialyllactose (6'SL) for use in i...
|
|
WO/2020/122435A1 |
The present invention relates to rice milk employing rice proteins and a manufacturing method therefor and, more particularly, to rice milk using rice proteins, which has a milk property as a rice zymolysis extract obtained by the enzyma...
|
|
WO/2020/123915A1 |
The present invention provides methods for the preparation of protein base compositions using antioxidants with heat treatment.
|
|
WO/2020/115324A1 |
A process for making a microparticulated whey protein concentrate, comprises the steps of providing a liquid whey protein concentrate (WPC), subjecting the liquid WPC to microparticulation to provide a microparticulated WPC, and optional...
|
|
WO/2020/117548A1 |
A method for providing a low lactose milk-based product having GOS fiber is provided in which a milk substrate having lactose is treated with a transgalactosylating enzyme to provide GOS fiber and remaining lactose; deactivating the tran...
|
|
WO/2020/118080A1 |
An alginate-based fiber is made of a composition comprising an alginate, a cellulose and a polyol plasticizer, such as glycerol. The fiber is produced through extrusion in a curing bath containing calcium. The fiber provides excellent st...
|
|
WO/2020/117447A1 |
The present invention relates to a multiple emulsion comprising or consisting of P1/0/W2, wherein P1 is an aqueous phase forming droplets or a gas phase forming bubbles, said droplets or bubbles being dispersed in O thereby forming P1/O,...
|
|
WO/2020/116383A1 |
The present invention addresses the problem of providing: a beverage having an activity to suppress the increase in blood pressure; and a method for producing the beverage. The present invention relates to: a beverage comprising kaempfer...
|
|
WO/2020/115196A1 |
The present invention relates to a device and a method for repeatedly modifying the composition of a fluid.
|
|
WO/2020/111980A1 |
The invention relates to the dairy industry. The present lactose production method provides for carrying out the ultrafiltration of skimmed milk or whey, carrying out the nanofiltration of the permeate, carrying out electrodialysis to a ...
|
|
WO/2020/098097A1 |
The present invention relates to the technical field of microbial fermentations, and in particular, to a lactobacillus plantarum and an application thereof. The strain has the classification and name of Lactobacillus plantarum and is pre...
|
|
WO/2020/101486A1 |
The invention provides a method for the generation of a bacteriophage insensitive mutant from parent strain cells comprising an active CRISPR-Cas system, the method comprising the stages: -an anti-CRISPR protein exposure stage comprising...
|
